www.fdanews.com/articles/132051-impax-drug-demonstrates-efficacy-and-safety-in-phase-iii-study

Impax Drug Demonstrates Efficacy and Safety in Phase III Study

November 18, 2010

Impax Pharmaceuticals, the brand products division of Impax Laboratories, Inc., Thursday announced positive top-line results of the APEX-PD Phase III clinical study with IPX066 in Parkinson’s disease.
FreshNews